FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/19/2025
Back to search
Official data from USPTO
XACTUS ONCO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/03/2026
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
10/17/2023
Registration date
12/31/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
KR
Examiner
CORNWELL, ANDREA B
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a dark green stylized cactus design to the left of the stylized wording "XACTUS ONCO" in which the "X" is dark green and red, "ACTUS" is dark green, and "ONCO" is gray.
Holders and representatives
Holders
XACTUS Onco Co., Ltd.
Representatives
Yan Song AEON Law, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of vaccines and medicines; development of cell therapy products; drug discovery services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; research and development of amino acid for medical purpose; research and development of peptide for medical purposes; research and development of technology for medicinal chemical manufacturing; analysis and evaluation of medical product development services to determine conformity with established accreditation standards; scientific research in the fields of medicinehealth and pharmacology; industrial research in the fields of medicinehealth and pharmacology; medical and scientific researchconducting clinical trials for others
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/26/2025
FIMP
FINAL DISPOSITION PROCESSED
06/26/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/17/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/29/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/29/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/31/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2024
PUBO
PUBLISHED FOR OPPOSITION
11/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/20/2024
RFNT
REFUSAL PROCESSED BY IB
07/20/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/29/2024
RFRR
REFUSAL PROCESSED BY MPU
06/29/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/15/2024
CNRT
NON-FINAL ACTION WRITTEN
06/06/2024
DOCK
ASSIGNED TO EXAMINER
06/03/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/25/2024
MAFR
APPLICATION FILING RECEIPT MAILED
12/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/30/2023
Continuous trademark protection
Get notified about every new filing that threatens XACTUS ONCO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.